pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-3821Research ArticleМАКСАВИН (ЛОМЕФЛОКСАЦИН) — МЕЖДУНАРОДНЫЙ ОПЫТ ЭКСПЕРИМЕНТАЛЬНОГО И КЛИНИЧЕСКОГО ИЗУЧЕНИЯ; МАТЕРИАЛ ПОДГОТОВЛЕН СПЕЦИАЛИСТАМИ ФИРМЫ “SEARIE”MAXAGUIN (LOMEFLOXACN): INTERNATIONAL EXPEIENCE OF EXPERIMENTAL AND CLINICAL STUDIES/ THE MATERIALS PROVIDED BY SEARLE’S SPECIALISTSОбзор исследований по безопасности МаксаквинаMaxaquin safety reviewРедакционнаяСтатьяEditorialArticle19932704202200Приложение3640Copyright © Редакционная С., 20222022Редакционная С.Editorial A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/3821
.
.
ReferencesСтруктура и антибактериальная активность Максакпипа / / Пульмонология.— 1993.— П рилож ение 1. —Структура и антибактериальная активность Максакпипа / / Пульмонология.— 1993.— П рилож ение 1. —Фармакоки нетические свойства Максаквипа / / Там же. —Фармакоки нетические свойства Максаквипа / / Там же. —Применение Максаквипа при лечении и профилактике инфекций мочевыводящих путей / / Там же.Применение Максаквипа при лечении и профилактике инфекций мочевыводящих путей / / Там же.Максаквин при лечении обострений хронического бронхита / / Там же.Максаквин при лечении обострений хронического бронхита / / Там же.Клиническая эффективность Максаквипа / / Там же.Клиническая эффективность Максаквипа / / Там же.Rizk Е. A worldwide clinical overview of lomefloxacin, a oncedaily fluoroquinolone / / Int. J. Antimicrob. Agents.— 1992.— Vol.' 2 .— P. 67— 78.Rizk Е. A worldwide clinical overview of lomefloxacin, a oncedaily fluoroquinolone / / Int. J. Antimicrob. Agents.— 1992.— Vol.' 2 .— P. 67— 78.Bednarczyk E .M ., Green J.A ., N elson A.D. et al. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen m etabolism in healthy subjects by positron emission tomography / / Pharmacotherapy.— 1992.— Vol. 12.— P. 369— 375.Bednarczyk E .M ., Green J.A ., N elson A.D. et al. Comparative assessment of the effect of lomefloxacin, ciprofloxacin, and placebo on cerebral blood flow, and glucose and oxygen m etabolism in healthy subjects by positron emission tomography / / Pharmacotherapy.— 1992.— Vol. 12.— P. 369— 375.. Ed lund C., Brismar B., Nord C.E. Effect of lomefloxacin on the normal oral and intestinal microflora / / Eur. J. Clin. Microbiol. Infect. Dis.— 1990.— Vol. 9.— P. 35— 39.. Ed lund C., Brismar B., Nord C.E. Effect of lomefloxacin on the normal oral and intestinal microflora / / Eur. J. Clin. Microbiol. Infect. Dis.— 1990.— Vol. 9.— P. 35— 39.Inagaki Y., Chid a T .t Nakaya R. et al. Effect of N Y -198, a new quinolone derivative, on human intestinal microflora / / Chemotherapy (Tokyo). — 1988.— Vol. 36, Suppl.2.— P. 120— 131.Inagaki Y., Chid a T .t Nakaya R. et al. Effect of N Y -198, a new quinolone derivative, on human intestinal microflora / / Chemotherapy (Tokyo). — 1988.— Vol. 36, Suppl.2.— P. 120— 131.Leigh D .A., Harris C., Tail S. et al. Pharm ocokinetic study of lomefloxacin and its effect on the faecal flora of volunteers / / J. Antimicrob. Chemother.— 1991.— Vol. 27. P. 655— 662.Leigh D .A., Harris C., Tail S. et al. Pharm ocokinetic study of lomefloxacin and its effect on the faecal flora of volunteers / / J. Antimicrob. Chemother.— 1991.— Vol. 27. P. 655— 662.Shim o Т., Matsuda K., Sailo A ., Yamazaki M . Arthrotoxicity study of NY -198 in rats / / Chemotherapy (Tokyo).— 1988.— Vol. 36, Suppl.2.— P. 439— 448.Shim o Т., Matsuda K., Sailo A ., Yamazaki M . Arthrotoxicity study of NY -198 in rats / / Chemotherapy (Tokyo).— 1988.— Vol. 36, Suppl.2.— P. 439— 448.Tesh J.M ., McAnully P .A ., W illoughby C.R. et al. Reproductive studies of N Y -198 in rats. I. Fertility studv / / Jpn. J. Antibiot.— 1988.— Vol. 41.— P. 1341 — 135LTesh J.M ., McAnully P .A ., W illoughby C.R. et al. Reproductive studies of N Y -198 in rats. I. Fertility studv / / Jpn. J. Antibiot.— 1988.— Vol. 41.— P. 1341 — 135LTesh J.M ., McAnulty P .A ., Willoughby C.R. et al. Reproductive studies of NY-198 in rats. II. Teratology studv / / Ibid.— P. 1352— 1369.Tesh J.M ., McAnulty P .A ., Willoughby C.R. et al. Reproductive studies of NY-198 in rats. II. Teratology studv / / Ibid.— P. 1352— 1369.Tesh J.M ., McAnully P .A ., Willoughby C.R. et al. Reproductive studies of N Y -198 in rats. III. Perinatal and postnatal study / / Ibid.— P. 1370— 1384.Tesh J.M ., McAnully P .A ., Willoughby C.R. et al. Reproductive studies of N Y -198 in rats. III. Perinatal and postnatal study / / Ibid.— P. 1370— 1384.UmemuraT., Sasa lL , Iizuka T ., YanagitaT. Teratalogical study of oral administration of N Y -198 in rabbits / / Chemotherapy (Tokyo).— 1988.— Vol. 36, Suppl.2.— P. 391— 410.UmemuraT., Sasa lL , Iizuka T ., YanagitaT. Teratalogical study of oral administration of N Y -198 in rabbits / / Chemotherapy (Tokyo).— 1988.— Vol. 36, Suppl.2.— P. 391— 410.Yamamoto K .-J.t Naitoh Y., Inone Y. et al. Seizure discharges induced by the combination of a new quinolinecarboxylic acid antimicrobial drugs and non-steroidal anti-inflammatory drugs. Effect of NY-198 on the central nervous system V / Ibid.— P. 300— 324.Yamamoto K .-J.t Naitoh Y., Inone Y. et al. Seizure discharges induced by the combination of a new quinolinecarboxylic acid antimicrobial drugs and non-steroidal anti-inflammatory drugs. Effect of NY-198 on the central nervous system V / Ibid.— P. 300— 324.Symonds W .T., Nix D.E. Lomefloxacin and temafloxacin: two new fluoroquinolone antim icrobials / / Clin. Pharm .— 1992.— Vol. 11.— P. 753— 766.Symonds W .T., Nix D.E. Lomefloxacin and temafloxacin: two new fluoroquinolone antim icrobials / / Clin. Pharm .— 1992.— Vol. 11.— P. 753— 766.Campoli-Richards D .M ., Monk J.P ., Price A. el al. Ciprofloxacin. A review of its antibacterial activity, pharm acokinetic properties and therapeutic use / / Drugs.— 1988.— Vol. 35.— P. 373— 447.Campoli-Richards D .M ., Monk J.P ., Price A. el al. Ciprofloxacin. A review of its antibacterial activity, pharm acokinetic properties and therapeutic use / / Drugs.— 1988.— Vol. 35.— P. 373— 447.Arcieri G., Griffith E., Gruenwaldt G. et al. Ciprofloxacin: an update on clinical experience / / Am. J. Med.— 1987. Vol. 82, Suppl.4A .— P. 381— 386.Arcieri G., Griffith E., Gruenwaldt G. et al. Ciprofloxacin: an update on clinical experience / / Am. J. Med.— 1987. Vol. 82, Suppl.4A .— P. 381— 386.Ball P. Ciprofloxacin: an overview of adverse experiences / / J. Antimicrob. Chemother.— 1986.— Vol. 18, Suppl.D.— P. 187— 193Ball P. Ciprofloxacin: an overview of adverse experiences / / J. Antimicrob. Chemother.— 1986.— Vol. 18, Suppl.D.— P. 187— 193Wang C., Sabbaj J., Corrado М ., Iloagland V. World-wide clinical experience with norfloxacin efficacy and safely / / Scand. J. Infect. Dis.— 1986.— Vol. 48, Suppl.— P. S I — S9.Wang C., Sabbaj J., Corrado М ., Iloagland V. World-wide clinical experience with norfloxacin efficacy and safely / / Scand. J. Infect. Dis.— 1986.— Vol. 48, Suppl.— P. S I — S9.Blom er R., Bruch K., Krauss II., W acheck W. Safely of ofloxacin— adverse drug reactions reported during phase-II studies in Europe and in Japan / / Infection.— 1986.— Vol. 14, Suppl.4.— P. S332— S334.Blom er R., Bruch K., Krauss II., W acheck W. Safely of ofloxacin— adverse drug reactions reported during phase-II studies in Europe and in Japan / / Infection.— 1986.— Vol. 14, Suppl.4.— P. S332— S334.Smith C.R. The adverse effects of fluoroquinolones III. Antimicrob. Chemother.— 1987.— Vol. 19.— P. 709— 711.Smith C.R. The adverse effects of fluoroquinolones III. Antimicrob. Chemother.— 1987.— Vol. 19.— P. 709— 711.Ilalkin II. Adverse effects of the fluoroquinolones / / Rev. Infect. Dis.— 1988.— Vol. 10, Suppl.1.— P. S258— S261.Ilalkin II. Adverse effects of the fluoroquinolones / / Rev. Infect. Dis.— 1988.— Vol. 10, Suppl.1.— P. S258— S261.Tatsum i II., Senda II., Yatera S. et al. Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals / / J. Tox. Sci.— 1978.— Vol. 3.— P. 357— 367.Tatsum i II., Senda II., Yatera S. et al. Toxicological studies on pipemidic acid. V. Effect on diarthrodial joints of experimental animals / / J. Tox. Sci.— 1978.— Vol. 3.— P. 357— 367.Schlufer G. Ciprofloxacin: review of potential toxicologic effects / / Am. J. Med.— 1987.— Vol. 82., Suppl.4A .— P. 91— 93.Schlufer G. Ciprofloxacin: review of potential toxicologic effects / / Am. J. Med.— 1987.— Vol. 82., Suppl.4A .— P. 91— 93.Schluter G. Toxicology of quinolones / / Forlschr. antim ikn antincoplast. Chemother.— 1987.— N 6— 10.— S. 1631 — 1642.Schluter G. Toxicology of quinolones / / Forlschr. antim ikn antincoplast. Chemother.— 1987.— N 6— 10.— S. 1631 — 1642.Christ W ., Lehnert Т., Ulbrich B. Specific toxicologic aspects of the quinolones / / Rev. Infect. Dis.— 1988.— Vol. 10, Suppl. 1.— P. S141— S146.Christ W ., Lehnert Т., Ulbrich B. Specific toxicologic aspects of the quinolones / / Rev. Infect. Dis.— 1988.— Vol. 10, Suppl. 1.— P. S141— S146.Stahlmann R ., Lode II. Safety overview: toxicity, adverse effects and drug interactions / / The Quinolones / Ed. V.T. Andriole.— New York: Academic Press, 1988.— P. 201— 233.Stahlmann R ., Lode II. Safety overview: toxicity, adverse effects and drug interactions / / The Quinolones / Ed. V.T. Andriole.— New York: Academic Press, 1988.— P. 201— 233.Stahlmann R. Safety profile of the quinolones / / J. Antimicrob. Chemother.— 990'.— Vol. 26, Suppl.D .— P. 31— 44.Stahlmann R. Safety profile of the quinolones / / J. Antimicrob. Chemother.— 990'.— Vol. 26, Suppl.D .— P. 31— 44.Gleckm an R., A lvarez S., Joubert D.W ., Matthews S.J. Drug therapy reviews: nalidixic acid / / Am. J. IIosp. P harm .— 1979.— Vol. 36.— P. 1071 — 1076.Gleckm an R., A lvarez S., Joubert D.W ., Matthews S.J. Drug therapy reviews: nalidixic acid / / Am. J. IIosp. P harm .— 1979.— Vol. 36.— P. 1071 — 1076.Simpson K .J., Brodie M .J. Convulsions related to cnoxacin / / Lancet.— 1985.— Vol. 2.— P. 161.Simpson K .J., Brodie M .J. Convulsions related to cnoxacin / / Lancet.— 1985.— Vol. 2.— P. 161.AnastasioG .D ., MenscerD ., Little J.M . Jr. Norfloxacin and seizures / / Ann. Intern. Med.— 1988.— Vol. 109.— P. 169— 170.AnastasioG .D ., MenscerD ., Little J.M . Jr. Norfloxacin and seizures / / Ann. Intern. Med.— 1988.— Vol. 109.— P. 169— 170.Lucet J.-C ., Tilly II., Lerebours G. et al. Neurological toxicity related to pefloxacin III. Antimicrob. C hem other.— 1988.— Vol. 21.— P. 811— 812.Lucet J.-C ., Tilly II., Lerebours G. et al. Neurological toxicity related to pefloxacin III. Antimicrob. C hem other.— 1988.— Vol. 21.— P. 811— 812.Tsuji A., Sato II., К ите Y. et al. Inhibitory effects of quinolone antibacterial agents on -am inobutyric acid binding to receptor sites on rat brain m embranes / / Antimicrob. Agents Chem other.— 1988.— Vol. 32.— P. 190— 194.Tsuji A., Sato II., К ите Y. et al. Inhibitory effects of quinolone antibacterial agents on -am inobutyric acid binding to receptor sites on rat brain m embranes / / Antimicrob. Agents Chem other.— 1988.— Vol. 32.— P. 190— 194.Akahane K., Sekiguchi М ., Une Т., Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with -am inobutyric acid receptor sites / / Ibid.— 1989.— Vol. 33.— P. 1704— 1708.Akahane K., Sekiguchi М ., Une Т., Osada Y. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with -am inobutyric acid receptor sites / / Ibid.— 1989.— Vol. 33.— P. 1704— 1708.Segev S., RehaviM ., Rubinstein E. Quinolones, theophylline and diclofenac interactions with the aminobutyric acid receptor / / Ibid.— 1988.— Vol. 32.— P. 1624— 1626.Segev S., RehaviM ., Rubinstein E. Quinolones, theophylline and diclofenac interactions with the aminobutyric acid receptor / / Ibid.— 1988.— Vol. 32.— P. 1624— 1626.Thorsteinsson S.B., Bergan Т., Oddsdoltir S. et al. C rystalluria and ciprofloxacin, influence of urinary pH and hydration / / Chemoterapy (B asel).— 1986.— Vol. 32.— P. 408— 417.Thorsteinsson S.B., Bergan Т., Oddsdoltir S. et al. C rystalluria and ciprofloxacin, influence of urinary pH and hydration / / Chemoterapy (B asel).— 1986.— Vol. 32.— P. 408— 417.
The authors declare that there are no conflicts of interest present.